Penn Ovarian Cancer Research Center
Ron Drapkin, MD, PhD, Director
Department of OBGYN
University of Pennsylvania
Biomedical Research Building
421 Curie Blvd., Rm. 1215
Philadelphia, PA 19104
Please visit: Drapkin Lab
The Penn Ovarian Cancer Research Center (OCRC), established in 2007, serves as a catalyst to promote comprehensive and interdisciplinary research on ovarian cancer in collaboration with the Jordan Center for Gynecologic Cancer, the Abramson Cancer Center, the Basser Center for BRCA, the Wistar Institute, and the Penn Immunotherapy Program, as well as numerous local, national and international investigators anc clinicans.
The OCRC has five major goals:
Develop new methods for early detection of ovarian cancer
Develop a comprehensive understanding of ovarian cancer pathogenesis
Characterize the genetic factors that drive the development of hereditary and sporadic forms of ovarian cancer
Develop new approaches to treat and prevent ovarian cancer
Support clinical trials to assess safety and efficacy of new treatments
The ultimate goal of these programs is to improve the quality of life for women with ovarian cancer and provide guidance and support to their families.